(NASDAQ: PETS) Petmed Express's forecast annual revenue growth rate of -1.81% is not forecast to beat the US Pharmaceutical Retailers industry's average forecast revenue growth rate of 24.89%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.31%.
Petmed Express's revenue in 2025 is $226,972,000.On average, 3 Wall Street analysts forecast PETS's revenue for 2026 to be $4,266,999,099, with the lowest PETS revenue forecast at $4,099,715,250, and the highest PETS revenue forecast at $4,392,461,987. On average, 3 Wall Street analysts forecast PETS's revenue for 2027 to be $4,394,143,231, with the lowest PETS revenue forecast at $4,221,815,648, and the highest PETS revenue forecast at $4,523,388,919.
In 2028, PETS is forecast to generate $4,514,352,229 in revenue, with the lowest revenue forecast at $4,337,191,066 and the highest revenue forecast at $4,647,170,562.